Skip to content

Comparing the Efficacy of Perioperative Pain Control Between Intravenous Parecoxib and Oral Etoricoxib in ACL Reconstruction: A Randomized Controlled Trial

Comparing the Efficacy of Perioperative Pain Control Between Intravenous Parecoxib and Oral Etoricoxib in ACL Reconstruction: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230916002
Enrollment
160
Registered
2023-09-16
Start date
2023-09-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior cruciate ligament injury patients which underwent anterior cruciate ligament reconstruction surgery. Post-operative pain, ACL reconstruction

Interventions

Etoricoxib 120 mg tablet oral q 24 hours + NSS 5 mL IV q 12 hours,Parecoxib 40 mg IV q 12 hours + placebo tablet oral q 24 hours
Experimental Drug,Active Comparator Drug
Etoricoxib,Parecoxib

Sponsors

Faculty of Medicine, Prince of Songkla University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: The patients diagnosed as anterior cruciate ligament injury aged 18-50 years old who scheduled for arthroscopic ACLR.

Exclusion criteria

Exclusion criteria: 1. Patient who schedules for bone-patellar tendon-bone autograft ACL reconstruction 2. Allergy to acetaminophen, aspirin, sulfonamide, NSAIDs or opioids 3. History of dyspepsia, peptic ulcer, or abnormal bleeding 4. History of ASCVD (History of diagnosis ACS, clinical likely ACS) 5. History of CKD 6. History of asthma or COPD because selective COX-inhibitor induce spasm 7. History of cerebrovascular disease 8. History of peripheral arterial disease 9. Patients who have Kratom or Marijuana used or substance abuse 10. Patients who anesthesiologist concerns the risk of general anesthesia (GA) is higher than spinal anesthesia; hence, they prefer to use spinal anesthesia rather than general anesthesia 11. Pre-operative abnormal EKG or laboratory result e.g., high Cr clearance, abnormal coagulogram

Design outcomes

Primary

MeasureTime frame
Pain score Every 4 hours from post-op until 48 hours Questionnaire, VNRS

Secondary

MeasureTime frame
Amount of rescue analgesic Within 24 hours post-op Medical record,Time to first dose of rescue analgesic Within 24 hours post-op Medical record,Side effect Within 48 hours post-op Questionnaire

Countries

Thailand

Contacts

Public ContactPhatklao Thanavirun

Department of Orthopedics, Faculty of Medicine, Prince of Songkla University

phatklao@gmail.com0818288390

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026